As of 2024-12-12, the Relative Valuation of United Therapeutics Corp (UTHR) is 574.23 USD. This relative valuation is based on P/E multiples. With the latest stock price at 362.16 USD, the upside of United Therapeutics Corp based on Relative Valuation is 58.6%.
The range of the Relative Valuation is 440.98 - 941.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.7x - 37.8x | 26.5x |
| Forward P/E multiples | 18.4x - 25.0x | 19.6x |
| Fair Price | 440.98 - 941.18 | 574.23 |
| Upside | 21.8% - 159.9% | 58.6% |
| Date | P/E |
| 2024-12-09 | 14.75 |
| 2024-12-06 | 14.85 |
| 2024-12-05 | 15.04 |
| 2024-12-04 | 15.04 |
| 2024-12-03 | 14.82 |
| 2024-12-02 | 14.87 |
| 2024-11-29 | 14.89 |
| 2024-11-27 | 15.19 |
| 2024-11-26 | 15.15 |
| 2024-11-25 | 14.81 |
| 2024-11-22 | 14.98 |
| 2024-11-21 | 14.76 |
| 2024-11-20 | 14.64 |
| 2024-11-19 | 14.49 |
| 2024-11-18 | 14.43 |
| 2024-11-15 | 14.60 |
| 2024-11-14 | 15.52 |
| 2024-11-13 | 16.09 |
| 2024-11-12 | 16.11 |
| 2024-11-11 | 16.09 |
| 2024-11-08 | 16.48 |
| 2024-11-07 | 16.18 |
| 2024-11-06 | 15.97 |
| 2024-11-05 | 15.38 |
| 2024-11-04 | 15.14 |
| 2024-11-01 | 15.03 |
| 2024-10-31 | 15.03 |
| 2024-10-30 | 14.52 |
| 2024-10-29 | 14.18 |
| 2024-10-28 | 14.05 |
| 2024-10-25 | 14.01 |
| 2024-10-24 | 14.07 |
| 2024-10-23 | 14.17 |
| 2024-10-22 | 14.88 |
| 2024-10-21 | 14.89 |
| 2024-10-18 | 14.80 |
| 2024-10-17 | 14.98 |
| 2024-10-16 | 14.87 |
| 2024-10-15 | 14.45 |
| 2024-10-14 | 14.35 |
| 2024-10-11 | 14.39 |
| 2024-10-10 | 14.24 |
| 2024-10-09 | 14.34 |
| 2024-10-08 | 14.30 |
| 2024-10-07 | 14.06 |
| 2024-10-04 | 14.30 |
| 2024-10-03 | 14.07 |
| 2024-10-02 | 14.16 |
| 2024-10-01 | 14.38 |
| 2024-09-30 | 14.40 |